Wesley D. Tate serves as Executive at CEREBAIN BIOTECH CORP., where they oversee executive responsibilities. Since joining the company, Wesley D. Tate has executed 6 insider transactions totaling $89.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 19, 2018 involved receiving (via award) 160,000 shares valued at $28.8K.
Wesley D. Tate currently holds 782,230 shares of CEREBAIN BIOTECH CORP. (DDOOD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wesley D. Tate has been a net buyer of DDOOD stock. They have purchased $89.4K and sold $0 worth of shares.
Wesley D. Tate's most recent insider trade was on Feb 19, 2018, when they sold 160,000 shares at $0.18 per share.
Get notified when new Form 4 filings are submitted
| $0.30 |
| Discretionary |
| Dec 15, 2015 | CBBT | $40.5K | Award | 150,000 | $0.27 | Discretionary |
| Sep 11, 2015 | CBBT | $77.5K | Award | 250,000 | $0.31 | Discretionary |
| Jun 16, 2014 | DDOOD | $51.9K | Purchase | 47,203 | $1.10 | Discretionary |
| Jun 16, 2014 | DDOOD | $37.5K | Purchase | 25,000 | $1.50 | Discretionary |